Data from EMC - Curated by Toby Galbraith - Last updated 19 October 2016

Indication(s)

Actelsar HCT 40 mg/12.5 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (40 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.


Actelsar HCT 80 mg/12.5 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.


Actelsar HCT 80 mg/25 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on Actelsar HCT 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more

Visit Type 2 Diabetes

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Actavis Group hf

Related Content